RB
Robert I Blum (President & CEO) filed 17 Form 4 reports in the trailing twelve months (0 purchases, 17 sales), most often in Cytokinetics, Incorporated (CYTK). The largest single filing was $7.3M of CYTK (105,426 sh across 2 lots, as filed), executed Sep 14. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
17
0 buys · 17 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$17.6M
shares × price, as filed
Last traded
Nov 2
Filed Nov 2
Median ADV $207.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $25.3M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
17 filings
Sector per market data · by filing · past 12 months
Most traded names
CYTKRecent filings
CYTKSALE
Cytokinetics, Incorporated
View filing →
$191K5,000 sh × $38.15
Exec Jul 14 2025
Filed Jul 15 2025 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $168K
5,000 sh × $33.55
Exec Jul 1 2025
Filed Jul 2 2025 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $169K
5,000 sh × $33.80
Exec Jun 16 2025
Filed Jun 16 2025 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $156K
5,000 sh × $31.22
Exec Jun 2 2025
Filed Jun 2 2025 · 5:30 PM ET